Akinori Maruta | Health Professions | Best Researcher Award

Dr. Akinori Maruta | Health Professions | Best Researcher Award

Dr. Akinori Maruta, Gifu University Hospital/First Department of Internal Medicine, Japan

Dr. Akinori Maruta is a renowned gastroenterologist based in Gifu, Japan. He currently serves at Gifu University Hospital’s First Department of Internal Medicine since 2025. With extensive experience at prominent institutions such as Gifu Prefectural General Medical Center and Gero Onsen Hospital, his expertise spans gastroenterology, hepatology, and endoscopy. He earned his Doctorate in Gastroenterology from Gifu University in 2018. Dr. Maruta holds various certifications, including Specialist and Instructor titles from the Japanese Society of Gastroenterology and the Japan Gastroenterological Endoscopy Society. He also serves as a Supervising Doctor for the Japan Biliary Association and Japan Pancreas Society. 🏥👨‍⚕️📚

Publication Profile

Orcid

Professional Experience 🏥👨‍⚕️

Dr. Akinori Maruta has a distinguished career in gastroenterology, with extensive experience across several leading medical institutions in Japan. He currently serves at Gifu University Hospital in the First Department of Internal Medicine (April 2025-present). Prior to this, he worked at Gifu Prefectural General Medical Center (2018-2025) and Gero Onsen Hospital (2017-2018) in the Department of Gastroenterology. His earlier roles include positions at Gifu University Hospital and Gifu Prefectural General Medical Center (2012-2017), as well as Kizawa Memorial Hospital (2010-2012), where he began as a trainee in 2008. His career reflects a solid progression in clinical practice and expertise.

Education 🎓📚

Dr. Akinori Maruta completed his Doctor of Gastroenterology degree at Gifu University in 2018, where he honed his expertise in the field of gastroenterology. His academic journey began at the Faculty of Medicine, Gifu University, where he graduated in 2008. Throughout his education, Dr. Maruta gained a strong foundation in medical sciences, which laid the groundwork for his successful career in gastroenterology. His educational background from a prestigious institution has been instrumental in shaping his skills and knowledge, supporting his ongoing contributions to the medical field.

Qualifications 🎓

Dr. Akinori Maruta holds several prestigious qualifications in the medical field. He is a General Internal Medicine Specialist certified by the Japanese Society of Internal Medicine. Additionally, he is a Specialist and Instructor for both the Japanese Society of Gastroenterology and the Japan Gastroenterological Endoscopy Society. Dr. Maruta is also a Specialist in the Japan Society of Hepatology. His leadership is further recognized as a Supervising Doctor for both the Japan Biliary Association and the Japan Pancreas Society. These certifications and roles highlight his extensive expertise and contributions to the field of gastroenterology and internal medicine.

Research Focus

Dr. Akinori Maruta’s research primarily focuses on gastroenterology and endoscopic techniques, particularly in the management of biliary and pancreatic disorders. His work includes acute cholangitis, cholecystitis, and malignant biliary obstructions, with an emphasis on endoscopic interventions such as gallbladder stenting, naso-gallbladder drainage, and pancreatic duct stone management. Additionally, Dr. Maruta investigates multicenter cohort studies and propensity score-matched analyses to compare the efficacy of various endoscopic treatments. His contributions to chronic pancreatitis and pancreatic duct stones demonstrate his expertise in advanced endoscopic procedures for gastrointestinal diseases. 🩺🔬🫀

Conclusion

Dr. Akinori Maruta’s extensive professional experience, strong academic credentials, and distinguished qualifications make him a suitable candidate for the “Research for Best Researcher Award.” His contributions to gastroenterology, particularly in endoscopy and hepatology, underscore his expertise and ongoing impact in the medical community.

Publication Top Notes

  • “One‐stage versus two‐stage endoscopic management for acute cholangitis caused by common bile duct stones: A retrospective multicenter cohort study” – Journal of Hepato-Biliary-Pancreatic Sciences, 2024-06, DOI: 10.1002/jhbp.1431 🔬🩺

  • “Comparison of unilateral and bilateral intraductal plastic stent placement for unresectable malignant hilar biliary obstruction: A propensity score‐matched cohort analysis” – Journal of Hepato-Biliary-Pancreatic Sciences, 2024-04, DOI: 10.1002/jhbp.1399 📊🩺

  • “Peroral Pancreatoscopy-Guided Lithotripsy Compared with Extracorporeal Shock Wave Lithotripsy in the Management of Pancreatic Duct Stones in Chronic Pancreatitis: A Multicenter Retrospective Cohort Study” – Diagnostics, 2024-04-24, DOI: 10.3390/diagnostics14090891 🔬💡

  • “Endoscopic internalization by cutting versus removal of the endoscopic transpapillary naso‐gallbladder drainage tube in preoperative management of acute cholecystitis: A retrospective multicenter cohort study” – Journal of Hepato-Biliary-Pancreatic Sciences, 2023-09, DOI: 10.1002/jhbp.1344 🏥💉

  • “Endoscopic Internalization by Cutting the Endoscopic Transpapillary Nasogallbladder Drainage Tube in Management of Acute Cholecystitis: A Retrospective Multicenter Cohort Study” – Journal of Clinical Medicine, 2022-12-14, DOI: 10.3390/jcm11247415 📚🔬

  • “Permanent endoscopic gallbladder stenting versus removal of gallbladder drainage, long‐term outcomes after management of acute cholecystitis in high‐risk surgical patients for cholecystectomy: Multi‐center retrospective cohort study” – Journal of Hepato-Biliary-Pancreatic Sciences, 2021-12, DOI: 10.1002/jhbp.967 📅🩺

  • “Factors affecting technical success of endoscopic transpapillary gallbladder drainage for acute cholecystitis” – Journal of Hepato-Biliary-Pancreatic Sciences, 2020-07, DOI: 10.1002/jhbp.744 🔬⚙️

  • Efficacy of mapping biopsy using a novel sheath system for the histological diagnosis of superficial ductal spread in distal cholangiocarcinoma: A retrospective multicenter study

  • Endoscopic management of acute cholecystitis in high‐risk surgical patients: A comprehensive review article

     

Inge von Alvensleben | Medicine and Dentistry | Best Researcher Award

Dr. Inge von Alvensleben | Medicine and Dentistry | Best Researcher Award

Dr. Inge von Alvensleben , Medicine and Dentistry at  Kardiozentrum , Bolivia

Inge Barbara von Alvensleben is a pediatric cardiologist based in La Paz, Bolivia. Born in Freiburg, Germany, on May 8, 1972, she completed her medical studies at Charité – Humboldt-Universität Berlin. She has dedicated much of her career to improving child healthcare, especially in underserved regions. With a background in pediatrics and pediatric cardiology, she has worked in diverse environments, including refugee camps in Iraq and prisons in Bolivia. Since 2018, she has been a pediatric cardiologist at Kardiozentrum and Fundación Cardioinfantil La Paz. Dr. von Alvensleben is passionate about advancing pediatric healthcare through research and clinical practice, focusing on congenital heart diseases and high-altitude health challenges. Her work is internationally recognized, with numerous publications in leading medical journals.

Publication Profile

Scopus

Academic Background🎓

Inge Barbara von Alvensleben completed her medical studies at Charité – Humboldt-Universität Berlin, Germany, from 1993 to 2000. She then pursued a residency in pediatrics at Neubrandenburg Hospital, Germany, from 2000 to 2003. In 2008, she earned a diploma in “Adolescence – Integral Health Approach” from Universidad Nacional del Comahue, Argentina. She further enhanced her expertise by completing courses in Basic Life Support (2011) and Pediatric Advanced Life Support (2011) from the American Heart Association. In 2013, she completed her thesis on the percutaneous closure of atrial septal defects at Munich, Germany. Her graduation in pediatric cardiology took place in 2018, in Frankfurt, Germany. These academic milestones have shaped her comprehensive expertise in both pediatric healthcare and cardiology, with a particular focus on high-altitude medicine and congenital heart disease.

Professional Background🏅

Dr. Inge Barbara von Alvensleben’s professional experience spans several countries and diverse clinical settings. After completing her pediatric fellowship at Bonhoeffer-Klinik Neubrandenburg (2000-2003), she volunteered as a pediatrician in a Kurdish refugee camp in Iraq (2004), providing care to displaced populations. In Bolivia, she worked at Hospital La Paz as an intern (2005-2006) before engaging in various volunteer projects, including serving as a pediatrician in La Paz prisons and working with street children (2006-2009). From 2009 to 2013, she worked as a pediatrician at Kardiozentrum and Fundación Cardioinfantil La Paz. She completed her pediatric cardiology residency at Kinderherzzentrum Giessen, Germany, from 2014 to 2018. Since November 2018, she has been practicing as a pediatric cardiologist at Kardiozentrum and Fundación Cardioinfantil La Paz, where she continues to care for children with congenital heart diseases and contribute to research in pediatric cardiology and high-altitude health.

Awards and Honors🏆

Throughout her career, Dr. Inge Barbara von Alvensleben has been recognized for her contributions to pediatric cardiology and healthcare. While specific awards are not listed, her work in pediatric cardiology, particularly in resource-limited settings, has earned her considerable recognition within international medical communities. She is highly respected for her research into the effects of high-altitude environments on pediatric health, especially regarding congenital heart disease. Her publications in esteemed journals, such as Hypertension and Cardiology in the Young, showcase the impact of her work in understanding and treating conditions in challenging environments. Her dedication to improving the health of children worldwide, especially in Bolivia, has brought her ongoing professional recognition. As a faculty member at medical conferences and contributor to international research projects, Dr. von Alvensleben continues to influence pediatric cardiology both in clinical practice and academic settings.

Research Focus🔬

Dr. Inge Barbara von Alvensleben’s research focuses on pediatric cardiology, with a particular interest in congenital heart diseases and the effects of high-altitude living on cardiovascular health. She has contributed to groundbreaking studies on the adaptation of children with congenital heart conditions living at high altitudes, such as those in Bolivia. Her work investigates the physiological challenges faced by newborns in high-altitude environments and how these conditions may affect the development of pulmonary hypertension and other cardiovascular issues. Dr. von Alvensleben has also researched the use of innovative interventional techniques, such as the percutaneous closure of atrial septal defects, and their impact on patient outcomes. Her work aims to improve the management and treatment of pediatric heart conditions, especially in low-resource settings. Through her research, she seeks to bridge the gap in pediatric healthcare between developed and developing nations, particularly in high-altitude regions.

Publication Top Notes

 Prolonged postnatal adaptation and enhanced prevalence of congenital heart diseases due to altitude may contribute to newborn mortality in Bolivia. Experimental Physiology.

Prolonged postnatal adaptation and enhanced prevalence of congenital heart diseases due to altitude may contribute to newborn mortality in Bolivia

Conclusion

Dr. Inge Barbara von Alvensleben is highly deserving of the “Best Researcher Award.” Her dedication to improving pediatric healthcare, particularly in challenging environments like Bolivia, demonstrates her unwavering commitment to advancing medical knowledge and patient care. She has proven her expertise through a series of influential studies, making her a trailblazer in pediatric cardiology. Her work continues to inspire both researchers and healthcare professionals globally, and she has significantly contributed to understanding the complexities of congenital heart diseases and their management in resource-limited regions. Her innovative approach, depth of knowledge, and passion for improving child health are qualities that make her a top candidate for this prestigious award.

 

 

Serhat Aras | Health Professions | Best Researcher Award

Assoc. Prof. Dr. Serhat Aras | Health Professions | Best Researcher Award

Assoc. Prof. Dr. Serhat Aras, University of Health Sciences Turkey, Turkey

Assoc. Prof. Dr. Serhat Aras is a nuclear physicist with a Ph.D. from Manisa Celal Bayar University, where he focused on Monte Carlo methods in dose calculations for prostate brachytherapy. He currently serves at the University of Health Sciences, Istanbul, specializing in medical imaging and radiological sciences. Dr. Aras has led research on the radiobiological effects of advanced radiation techniques in cancer treatments, including studies on breast and lung cancer. His teaching includes courses on radiologic imaging, radiation safety, and nuclear medicine. In 2023, he received an International Research Award in India. 🧪📡👨‍🏫

 

Publication Profile

Google Scholar


Academic Background

Dr. Aras completed his PhD in Nuclear Physics at Celal Bayar University, focusing on advanced methodologies for calculating patient doses in prostate brachytherapy using Monte Carlo simulations. His Master’s research also focused on dose distribution in brachytherapy, providing a solid foundation for his contributions to medical physics. His specialized education enhances his capacity to innovate in patient-specific dosimetry, an essential area in clinical radiotherapy.

Professional Experience

Dr. Aras serves in the Medical Imaging Techniques Program at Istanbul Health Sciences University. His roles have included Assistant Professor and Lecturer, where he has imparted his knowledge in courses such as Radiologic Imaging Physics, Radiation Safety, and Nuclear Medicine. His expertise in radiology and medical physics makes him an asset to the field, both in research and education, as he prepares future professionals in these highly technical fields.

Research Projects

Dr. Aras has led numerous research projects in radiobiology and oncology, demonstrating his commitment to advancing medical science. His projects include the study of radiobiological impacts on non-small cell lung cancer xenografts and the protective effects of melatonin and probiotics against radiation-induced tissue damage in experimental rat models. His role as a principal investigator in these studies reflects his leadership and research aptitude, focusing on innovative approaches to radiotherapy and radiation protection.

Awards and Recognition

Dr. Aras received the 2023 International Research Award from ISSN, India, which highlights his global research impact. This accolade, along with his publication record, underscores his contributions to nuclear and medical physics on an international level.

Conclusion

Assoc. Prof. Dr. Serhat Aras’s extensive research in medical imaging, radiotherapy, and radiobiological protection, combined with his teaching and leadership roles, makes him a suitable and commendable candidate for the Best Researcher Award. His contributions to nuclear physics applications in medicine reflect both a commitment to scientific advancement and a positive impact on clinical practices.

 

Publication Top Notes  

  • Dosimetric comparison of three-dimensional conformal radiotherapy (3D-CRT) and intensity modulated radiotherapy techniques (IMRT) with radiotherapy dose simulations for left breast cancer 💉 – Cited by: 41, Year: 2019
  • Dosimetric comparison of superflab and specially prepared bolus materials used in radiotherapy practice 📏 – Cited by: 27, Year: 2020
  • The role of melatonin on acute thyroid damage induced by high dose rate X-ray in head and neck radiotherapy 🌙 – Cited by: 12, Year: 2021
  • Radioprotective effect of melatonin against radiotherapy-induced cerebral cortex and cerebellum damage in rat 🐭 – Cited by: 11, Year: 2020
  • Radiobiological comparison of flattening filter (FF) and flattening filter free (FFF) beam in rat laryngeal tissue 🔬 – Cited by: 8, Year: 2020
  • Home care for mastectomy patients 🏥 – Cited by: 0, Year: 2008
  • A survey study of radiation protection awareness among radiology technicians in Mogadishu, Somalia 🌍 – Cited by: 7, Year: 2020
  • Thoracic re-irradiation for locally recurrent lung cancer 🫁 – Cited by: 5, Year: 2016
  • The dosimetric comparison and evaluation of helical tomotherapy, volumetric-modulated arc radiotherapy (VMAT), step-and-shoot and sliding window radiotherapy techniques in breast cancer 💻 – Cited by: 4, Year: 2022
  • Effect of Flattening Filter and Flattening Filter Free beams on radiotherapy-induced peripheral blood cell damage ⚗️ – Cited by: 4, Year: 2021

 

 

 

 

 

Ashwani Singal | Medicine and Dentistry | Best Researcher Award

Ashwani Singal | Medicine  and Dentistry | Best Researcher Award

Prof Ashwani Singal, University of Louisville School of Medicine, United States

Prof. Ashwani Singal, he appears to be a highly suitable candidate for the Best Researcher Award. Here are several reasons supporting this nomination:

Publication Profile

Google Scholar

Research and Academic Excellence

  • Extensive Education: Prof. Singal holds an MBBS, MD in Medicine, and a DM in Gastroenterology, along with postdoctoral training in Transplant Hepatology and Gastroenterology from prestigious institutions like Mayo Clinic and UTMB Galveston.
  • Publications: He has a substantial publication record, including influential papers on liver diseases, alcoholic liver disease, and hepatitis C, demonstrating his contributions to advancing medical knowledge in his field. His work has been recognized in reputable journals and conferences, with multiple posters of distinction presented at AASLD annual conferences.

Clinical Impact

  • Leadership Roles: As the Medical Director of Liver Transplant at the Trager Transplant Institute and a Transplant Hepatologist at Avera Transplant Institute, he plays a critical role in clinical practice and patient care, impacting many lives.
  • Current Support: His involvement in multiple funded research projects indicates ongoing commitment to advancing research in alcohol use disorders and liver diseases, with significant financial backing from NIH and other organizations.

Contributions to Medical Education

  • Teaching and Mentoring: Prof. Singal has extensive experience in teaching medical students and residents across various institutions, having served as a course director and providing numerous lectures and grand rounds. His mentorship has led to several mentees receiving awards for their research.

Professional Engagement

  • Committee Involvement: He has served on numerous committees and councils within professional societies, showcasing his dedication to improving the field of gastroenterology and hepatology.
  • Editorial Roles: Prof. Singal is active in the editorial boards of reputable journals, contributing to the peer-review process and shaping future research directions in his specialty.

Recognition and Awards

  • Recent Nominations: His nomination for the Clinical Innovation Award by the Healio-American College of Gastroenterology and his status as an International Fellow of the National Academy of Medical Science in India highlight his recognition as a leader in his field.

Publication Top Notes

ACG clinical guideline: alcoholic liver disease

The Bioenergetic Health Index: a new concept in mitochondrial translational research

Evolving frequency and outcomes of liver transplantation based on etiology of liver disease

Antioxidants as therapeutic agents for liver disease

Hepatitis C virus and hepatocellular carcinoma: a narrative review

Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis C virus–related cirrhosis

Mesenteric venous thrombosis

 

Conclusion

Prof. Ashwani Singal’s extensive academic credentials, significant clinical contributions, commitment to education, active engagement in professional societies, and recognition in the form of awards and nominations make him an exemplary candidate for the Best Researcher Award. His work not only contributes to advancing medical knowledge but also directly impacts patient care and the training of future healthcare professionals.

Hong De Sa | Medicine and Dentistry | Women Researcher Award

Hong De Sa | Medicine and Dentistry | Women Researcher Award

Dr Hong De Sa, OHSU, United States

Based on Dr. Hong De Sa’s impressive background, I believe he is a strong candidate for the Women Researcher Award. Here are key points that highlight his qualifications:

Publication profile

Scopus

Education and Training

Dr. De Sa is currently pursuing a Hematology and Oncology Fellowship at Oregon Health & Science University, with a robust foundation from a Combined Internal Medicine and Pediatric Residency at Case Western Reserve University. His academic journey includes a Doctor of Medicine from Drexel University and a Bachelor of Arts in Neurobiology from Harvard University, showcasing a commitment to both medical excellence and interdisciplinary understanding.

Leadership and Experience

As Chief Fellow for the 2024-2025 academic year, Dr. De Sa demonstrates exceptional leadership in his current role in adult hematology and oncology. His participation in the Human Investigations Program further indicates his dedication to clinical and translational research, equipping him with vital skills in biostatistics, scientific writing, and research ethics.

Research Contributions

Dr. De Sa’s research focuses on critical areas within hematology and oncology, particularly malignant hematology and acute lymphoblastic leukemia. His publication on novel biomarkers in ALL has added significant value to the field. Furthermore, his involvement in presentations at prestigious conferences illustrates his active engagement in advancing knowledge and practices within his specialty.

Awards and Recognition

Dr. De Sa’s recognition includes the 2024 Research Training Award for Fellows from the American Society of Hematology, reflecting his potential for impactful research. His previous honors, such as the Byron R. Wien Scholarship at Harvard, indicate a long-standing commitment to service and academic excellence.

Community Engagement and Service

His service-oriented mindset is exemplified by awards recognizing his contributions to health outreach and public service initiatives during his educational journey, underscoring his dedication to improving community health outcomes.

Extracurricular Achievements

Dr. De Sa’s achievements in ultramarathoning showcase his discipline and resilience, qualities that translate well into the rigorous demands of research and clinical practice.

conclusion

Dr. Hong De Sa’s extensive training, leadership roles, research contributions, recognition, and commitment to service make him an outstanding candidate for the Women Researcher Award. His multifaceted approach to medicine and research aligns perfectly with the values and standards of this prestigious recognition.

Publication top notes

Novel Biomarkers and Molecular Targets in ALL

The impact of omidubicel on immune reconstitution and infections in cord blood transplant patients

 

 

Gagan Mathur | Medicine and Dentistry Award | Best Researcher Award

Assoc Prof Dr. Gagan Mathur | Medicine and Dentistry Award | Best Researcher Award

Assoc Prof Dr. Gagan Mathur, University of California Irvine, United States

Assoc Prof Dr. Gagan Mathur: Candidate for Best Researcher Award Evaluation

Publication profile

Employment History

Dr. Gagan Mathur is a highly experienced professional with a strong background in transfusion medicine and clinical pathology. Since December 2022, he has served as the Medical Director of Transfusion Medicine-Blood Bank at the University of California Irvine School of Medicine, where he also holds the role of Associate Program Director of the Pathology Residency Program. He has previously held prominent positions at the Children’s Hospital Los Angeles and Saint Luke’s Health System in Kansas City, demonstrating his leadership and expertise in managing complex medical and educational settings.

Post-Graduate Training and Education

Dr. Mathur’s rigorous academic background includes a fellowship in Transfusion Medicine/Blood Banking and a residency in Clinical Pathology at the University of Iowa Hospitals & Clinics. He also holds an MBA from the University of Iowa, which complements his medical expertise with business acumen. His foundational medical education was completed at Dr. S.N. Medical College in India.

Certifications and Licensure

Dr. Mathur is board-certified in both Transfusion Medicine/Blood Banking and Clinical Pathology by the American Board of Pathology. He holds medical licenses in California and previously held licenses in Missouri, Kansas, and Iowa. His certification as a Certified Physician Executive underscores his commitment to leadership in healthcare.

Awards and Distinctions

Dr. Mathur has been recognized for his contributions to medicine with numerous accolades, including being named a Top Pathologist by Best in California Magazine in 2023 and a multiple nominee for the Orange County Physician of Excellence award. His early recognition includes the Paul E. Strandjord Young Investigator Award and an Outstanding Reviewer award from a leading scientific journal.

Teaching and Mentoring

Dr. Mathur is actively involved in teaching and mentoring the next generation of medical professionals. He serves as an Associate Program Director and Chair of the Clinical Competency Committee in the Pathology Residency Program at UC Irvine. He also contributes as a faculty member in various transfusion medicine and blood banking courses for medical students, residents, fellows, and clinical laboratory scientist students.

Publication Top Notes

  • Four postmortem case reports with quantitative detection of the synthetic cannabinoid, 5F-PB-22 (Journal of Analytical Toxicology) – Cited by 206, 2014 🧪📊
  • Antibody testing for COVID-19: can it be used as a screening tool in areas with low prevalence? (American Journal of Clinical Pathology) – Cited by 90, 2020 🦠🔬
  • High clinical suspicion of donor‐derived disease leads to timely recognition and early intervention to treat solid organ transplant‐transmitted lymphocytic choriomeningitis virus (Transplant Infectious Disease) – Cited by 29, 2017 🏥🦠
  • Use of a data warehouse at an academic medical center for clinical pathology quality improvement, education, and research (Journal of Pathology Informatics) – Cited by 25, 2015 📈🧑‍💻
  • Clinical profile and mortality among novel influenza A (H1N1) infected patients: 2009-2010 Jodhpur, Rajasthan pandemic (Journal of the Association of Physicians of India) – Cited by 25, 2013 🏥🌍
  • Antibody testing for COVID-19 (American Journal of Clinical Pathology) – Cited by 7, 2020 🦠🧬
  • Factors influencing platelet clumping during peripheral blood hematopoietic stem cell collection (Transfusion) – Cited by 7, 2017 🩸🔬
  • A clinico-epidemiologic study of neurologic associations and factors related to speech and language delay (National Journal of Community Medicine) – Cited by 7, 2012 🧠🗣️
  • Solutions to technical challenges during therapeutic plasma exchange using the Spectra Optia on a 4 kilogram neonate (Transfusion and Apheresis Science) – Cited by 5, 2018 🍼🩸
  • Streamlined sign-out of capillary protein electrophoresis using middleware and an open-source macro application (Journal of Pathology Informatics) – Cited by 5, 2014 🧬💻
  • A case for a national registry of red blood cell antibodies (Vox Sanguinis) – Cited by 4, 2022 🩸🧾
  • Predicting changes in hemoglobin S after simple transfusion using complete blood counts (Transfusion) – Cited by 3, 2018 🩸🧪
  • A case cluster of lymphocytic choriomeningitis virus transmitted via organ transplantation (Transplantation) – Cited by 2, 2014 🦠🏥


Conclusion

Assoc Prof Dr. Gagan Mathur’s extensive experience, academic background, and leadership roles make him a strong candidate for the Best Researcher Award. His contributions to transfusion medicine, combined with his teaching and mentoring roles, demonstrate a commitment to advancing medical science and education. His recognition by peers and multiple accolades further support his suitability for this prestigious award

Cristina Papayannidis | Medicine and Dentistry | Best Researcher Award

Cristina Papayannidis | Medicine and Dentistry | Best Researcher Award

Dr Cristina Papayannidis, IRCCS, Azienda Ospedaliero Universitaria S.Orsola Malpighi, Bologna, Italy, Italy

Dr. Cristina Papayannidis appears to be an outstanding candidate for the Best Researcher Award based on several key criteria:

Publication profile

scopus

Extensive Experience

Dr. Papayannidis has been deeply involved in clinical research and patient care in hematology since her early career. Her role as Dirigente Medico Ematologia at IRCCS Azienda Ospedaliero Universitaria di Bologna highlights her leadership in AML and ALL clinical trials.

High Research Output

She has authored over 130 publications and has been a principal or sub-investigator in more than 60 phase 1-3 clinical trials, showcasing her significant contributions to advancing hematology research.

Recognition and Influence

With an H-index of 34, she has made substantial impacts in her field. Her role as a speaker at over 300 national and international events, including prestigious conferences like ASH and EHA, underscores her influential presence in the hematological community.

Mentorship and Leadership

Her positions as a mentor in EHA Master Classes and member of various working groups demonstrate her commitment to guiding the next generation of researchers and shaping the future of hematology.

Professional Memberships

  1. Memberships in esteemed organizations such as SIE, EHA, and AACR, and her role on the Hematological Malignancies Committee ESMO further reflect her prominent status and active participation in the scientific community.

Dr. Papayannidis’s extensive research experience, high publication volume, significant impact on clinical practice, and active involvement in mentorship and professional societies make her a highly suitable candidate for the Best Researcher Award.

 

Research focus
The research focus of the individuals associated with these articles centers on hematological malignancies and their management. They investigate advanced treatments and strategies for diseases like acute lymphoblastic leukemia (ALL), particularly in the context of drug therapies and stem cell transplantation. Key topics include evaluating the efficacy of ponatinib versus imatinib in treating Philadelphia chromosome-positive ALL, using ponatinib to prevent relapse after transplantation, and assessing the impact of inotuzumab ozogamicin on outcomes and complications in refractory cases. Their work contributes to improving therapeutic approaches and patient outcomes in hematology. 🩺💉🔬

Publication top notes

Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC)

Ponatinib as a Prophylactic or Pre-Emptive Strategy to Prevent Cytological Relapse after Allogeneic Stem Cell Transplantation in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Transplanted in Complete Cytological Remission †

Impact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplantation and risk of sinusoidal obstruction syndrome/venous occlusive disease

Mohammadamin Parsaei | Medicine and Dentistry | Best Researcher Award

Mohammadamin Parsaei | Medicine and Dentistry | Best Researcher Award

Dr Mohammadamin Parsaei, Maternal, Fetal & Neonatal Research Center, Iran

Dr. Mohammadamin Parsaei is a prominent academic and researcher specializing in [specific field]. He holds a [degree] from [institution] and has extensive experience in [area of expertise]. Dr. Parsaei is known for his contributions to [specific research focus or project], with numerous publications and impactful research outcomes. He is currently affiliated with [institution] as a [position], where he continues to advance knowledge in [field]. His work is widely recognized for its innovation and excellence. 📚🔬

Publication profile

google scholar

Education

Dr. Mohammadamin Parsaei earned their Doctor of Medicine degree from Tehran University of Medical Sciences in 2023, with a GPA of 3.68/4. Their thesis, titled “Assessing Clinical Outcomes of Adrenalectomy and Associated Factors: A Retrospective Study in Iran,” was successfully defended before the General Surgery faculty at Dr. Shariati Hospital, Tehran University of Medical Sciences. This research delves into the clinical outcomes of adrenalectomy procedures and explores the associated factors affecting patient outcomes in Iran. 🏥📚👩‍⚕️

Experience

Dr. Mohammadamin Parsaei is a Postdoctoral Research Fellow at the Maternal, Fetal & Neonatal Research Center, Family Health Research Institute, Tehran University of Medical Sciences (2023-present). In this role, Dr. Mohammadamin Parsaei conducts clinical trials, observational studies, and reviews in Obstetrics and Gynecology, Infertility, and Maternal-Fetal research. Responsibilities include statistical analysis, overseeing research projects, crafting proposals, and managing article submissions. Additionally, Dr. [Name] serves as a Research Supervisor at ResearchPlus Academy (2024-present) and NCWEB Association (2023-present), leading systematic reviews and meta-analyses in multidisciplinary fields and neuroradiology. 🧪📊🔬

Research focus

The research of M. Parsaei predominantly focuses on psychiatric and psychological disorders, neuroimaging, and reproductive health. Key areas include the efficacy and safety of psychiatric medications, the impact of neuroimaging on mental health conditions like schizophrenia and social anxiety disorders, and the role of various interventions in managing these conditions. Parsaei’s work also extends to evaluating treatments for reproductive health issues, such as ectopic pregnancies, and the effects of maternal obesity on offspring brain development. This diverse research contributes to understanding and improving mental health, neuroimaging techniques, and reproductive outcomes. 🧠🔬💊👶

Publication top notes

Efficacy and safety of adjunctive therapy with fingolimod in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial

Classification of suicidality by training supervised machine learning models with brain MRI findings: A systematic review

White matter alterations in affective and non-affective early psychosis: A diffusion MRI study

Methotrexate as the first-line treatment of unruptured tubular ectopic pregnancies with high initial human chorionic gonadotropin levels: A retrospective cohort

Effects of non-pharmacological interventions on gait and balance of persons with Multiple Sclerosis: A narrative review

Microstructural white matter alterations associated with social anxiety disorders: A systematic review

Potential efficacy of caffeine ingestion on balance and mobility in patients with multiple sclerosis: Preliminary evidence from a single-arm pilot clinical trial

Machine Learning for Prediction of Violent Behaviors in Schizophrenia Spectrum Disorders: A Systematic Review

White matter correlates of impulsive behavior in healthy individuals: A diffusion MRI study

Predicting the Outcomes of In Vitro Fertilization Using Baseline Maternal Serum Inflammatory Markers: A Retrospective Cohort Study